The Duchenne Registry (Previously DuchenneConnect) | DuchenneXchange

welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

The Duchenne Registry (Previously DuchenneConnect)

key information

study id #: NCT02069756

condition: Duchenne Muscular Dystrophy, Becker Muscular Dystrophy

status: recruiting


DuchenneConnect is an online, patient-report registry for individuals with Duchenne and Becker muscular dystrophy and carrier females. The purpose of DuchenneConnect is to connect Duchenne and Becker patients with actively recruiting clinical trials and research studies, and to educate patients and families about Duchenne and Becker care and research. At the same time, DuchenneConnect is a valuable resource for clinicians and researchers in academia and industry, allowing access to a de-identified, aggregate dataset provided by patients and their families—information that is vital to advances in the care and treatment of Duchenne. DuchenneConnect is a member of PCORnet, the National Patient-Centered Clinical Research Network.

mechanism of action: No pharmaceutical intervention


last updated: November 22, 2018

study details

start date: October 2007

estimated completion: October 2027

size / enrollment: 10000

study description:
DuchenneConnect was created in 2007 by Parent Project Muscular Dystrophy (PPMD), with assistance from the NIH, the CDC, and Emory Genetics. In early 2011, PPMD alone began financing the registry's operation and maintenance, and is the sole guardian of DuchenneConnect and its material.
Questions may be addressed to the DuchenneConnect Coordinators at telephone 888-520-8675 or The DuchenneConnect Coordinators are certified genetic counselors who are available to answer questions regarding the registration process, genetic testing and counseling, and clinical trials and research studies.

primary outcomes:

  • Genetic mutation [ Time Frame: Registrants are requested to update their medical history every 6-12 months, and they will be followed throughout their lifetime. ]
    Genetic mutation data is collected by patient report and verified by curation/review of genetic test report when provided. Genetic test report is requested for each registrant and is required for participation in global DMD (TREAT-NMD) registry.

secondary outcomes:

  • Ambulation status [ Time Frame: Registrants are requested to update their medical history every 6-12 months, and they will be followed throughout their lifetime. ]
    Ambulation status is assessed from several questions about mobility, ability to sit and stand, use of assistive devices, and age at full time wheelchair use.

inclusion criteria:
Diagnosis of Duchenne or Becker muscular dystrophy; Manifesting female carriers and asymptomatic female carriers also included in registry.

exclusion criteria:
Diagnosis of any other type of muscular dystrophy (including limb-girdle muscular dystrophy).

study contacts

sponsor: The Duchenne Registry

contacts: Ann Martin, MS, CGC, 888-520-8675,

locations: United States